Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Insert Pic Of Swirling Toilet Here

<< Previous

Bullboard Posts

Next >>

Post by Valuehunter72on Jun 15, 2020 12:34pm

134 Views

Post# 31151607

Insert Pic Of Swirling Toilet Here

No update once again. CEO has opportunity now that second wave is starting...remains silent however. Why are they silent? Perhaps they need to justify the low price they worked it down to for the cheap PP? All buddies can load up at 8.5 now with 13 cent warrant. High fives all around....then bring out the news. Nice. What about the Strategic Innovation Fund David? How are lab trials going that you have not updated shareholders on on weeks? Any developments on partnerships that you were seeking months back? Have any further warrants been exercised?

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources